Home › Funds › TANG CAPITAL MANAGEMENT LLC › AUPH

TANG CAPITAL MANAGEMENT LLC position in AUPH

AURINIA PHARMACEUTICALS · Health Care

TANG CAPITAL MANAGEMENT LLC reported holding 13,044,106 shares of AUPH (AURINIA PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$221.4M, representing 10.05% of its reported portfolio and ranking #1 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed AUPH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)13.04M sh
Reported value held$221.36M
Portfolio Weight10.05%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TANG CAPITAL MANAGEMENT LLC's AUPH position evolved

TANG CAPITAL MANAGEMENT LLC first disclosed a stake in AUPH in Q3 2023 at 750,000 shares (US$5.8M). The position peaked in Q2 2026 at 13,044,106 shares, worth US$221.4M. Across 12 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 8 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 13,044,106 shares valued at US$221.4M — an increase of 814,606 shares quarter over quarter.. Notable position changes include a 273% increase in Q1 2024 (shares rose 14% over the following quarter), a 36% increase in Q2 2024 (shares rose 28% over the following quarter), a 160% increase in Q3 2024 (shares rose 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 750.00K $5.83M New
Q4 2023 550.00K $4.94M Reduce
Q1 2024 2.05M $10.27M Add
Q2 2024 2.78M $15.87M Add
Q3 2024 7.23M $52.99M Add
Q4 2024 8.43M $75.70M Add
Q1 2025 10.03M $80.64M Add
Q2 2025 10.03M $84.95M Hold
Q3 2025 11.33M $125.19M Add
Q4 2025 11.33M $180.71M Hold
Q1 2026 12.23M $181.24M Add
Q2 2026 13.04M $221.36M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AUPH and 13F data

AUPH (AURINIA PHARMACEUTICALS) is a Health Care company. 49 other funds we track also report a position in AUPH — the largest reported positions include NEA Management Company, LLC (US$67.4M), Norris Financial Group, LLC (US$5.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AUPH

All AUPH fund holders →

FAQ

How long has TANG CAPITAL MANAGEMENT LLC held AUPH?

TANG CAPITAL MANAGEMENT LLC has disclosed AUPH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is TANG CAPITAL MANAGEMENT LLC's current position in AUPH?

As of Q2 2026, TANG CAPITAL MANAGEMENT LLC holds 13.04M shares of AUPH (AURINIA PHARMACEUTICALS), valued at $221.36M, representing 10.05% of its reported portfolio and ranking #1.

Has TANG CAPITAL MANAGEMENT LLC been buying or selling AUPH?

In the latest 13F filing (Q2 2026), TANG CAPITAL MANAGEMENT LLC increased its position in AUPH. The position peaked in Q2 2026 at 13.04M shares.

Which other funds hold AUPH?

Other major institutional holders of AUPH include NEA Management Company, LLC, Norris Financial Group, LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.